Bad day for drugs and oil see FTSE end week under 4,700

clock

A major loss in the share price of oil exploration company Cairn Energy along with AstraZeneca pulled the FTSE 100 index back under 4,700 after a stronger week.

The FTSE 100 index eventually closed down 38.4 points or 0.81% to 4,696.8 after Cairn Energy announced its exploration of Rajasthan will now generate lower reserves than initially estimated – down to around one-fifth of predicted reserves - along with the threat of a royalty tax worth $3 a barrel by the Indian government. This dragged Cairn’s share value down a whopping 247p or 18% to £11.15. European drugs firm AstraZeneca also lost 170p or 8.2% to £18.86 after announcing its Iressa lung cancer drug didn't help patients as hoped, when trialled in its study, pulling rival firm GlaxoSmith...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

What does 2026 hold for investment?

What does 2026 hold for investment?

‘The disruptors of yesterday are now the establishment’

Jen Frost
clock 17 December 2025 • 3 min read
FCA launches trio of crypto consultations as UK interest nears tipping point

FCA launches trio of crypto consultations as UK interest nears tipping point

Consumer protection and innovation

Patrick Brusnahan
clock 16 December 2025 • 2 min read
Cryptoasset legislation in UK to come into force in 2027

Cryptoasset legislation in UK to come into force in 2027

Consumer protection

Cristian Angeloni
clock 15 December 2025 • 1 min read